The Patient Capital Review may be of all-consuming interest to those who work in the tax-advantaged investment sector but, if you are only after a summary of the salient points, Jack Rose is happy to oblige
For those of us who work within the tax-advantaged investment sector, the impending outcome of the Patient Capital Review (PCR) - its possible permutations and consequences - is the talk of the town. ...
Has entered world of face-to-face advice
Four key risks
37 counts of fraud
E-learning an option
The end of Goldilocks?